Generation and characterization of telomerase transfected human lymphatic endothelial cells with an extended life span

被引:86
作者
Nisato, RE
Harrison, JA
Buser, R
Orci, L
Rinsch, C
Montesano, R
Dupraz, P
Pepper, MS
机构
[1] Univ Geneva, Med Ctr, Dept Morphol, CH-1211 Geneva 4, Switzerland
[2] Isotis SA, Lausanne, Switzerland
关键词
D O I
10.1016/S0002-9440(10)63271-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The study of lymphatic endothelial cells and lymphangiogenesis has, in the past, been hampered by the lack of lymphatic endothelial-specific markers. The recent discovery of several such markers has permitted the isolation of lymphatic endothelial cells (LECs) from human skin. However, cell numbers are limited and purity is variable with the different isolation procedures. To overcome these problems, we have transfected human dermal microvascular endothelial cells (HDMVECs) with a retrovirus containing the coding region of human telomerase reverse transcriptase (hTERT), and have produced a cell line, hTERT-HDLEC, with an extended lifespan. hTERTHDLEC exhibit a typical cobblestone morphology when grown in culture, are contact-inhibited, and express endothelial cell-specific markers. hTERTHDLEC also express the recognized lymphatic markers, Prox-1, LYVE-1 and podoplanin, as well as integrin alpha9, but do not express CD34. They also form tube-like structures in three-dimensional collagen gels when stimulated with vascular endothelial growth factors -A and -C. Based on these currently recognized criteria, these cells are LEC. Surprisingly, we also found that the widely studied HMEC-1 cell line expresses recognized lymphatic markers; however, these cells are also CD34-positive. In summary, the ectopic expression of hTERT increases the life span of LECs and does not affect their capacity to form tubelike structures in a collagen matrix. The production and characterization of hTERT-HDLEC will facilitate the study of the properties of lymphatic endothelium invitro.
引用
收藏
页码:11 / 24
页数:14
相关论文
共 50 条
  • [11] Human vascular endothelial cells with extended life spans: In vitro cell response, protein expression, and angiogenesis
    Gagnon E.
    Cattaruzzi P.
    Griffith M.
    Muzakare L.
    LeFlaol K.
    Faure R.
    Béliveau R.
    Hussain S.N.
    Koutsilieris M.
    Doillon C.J.
    [J]. Angiogenesis, 2002, 5 (1-2) : 21 - 33
  • [12] CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells
    Griffioen, AW
    Coenen, MJH
    Damen, CA
    Hellwig, SMM
    vanWeering, DHJ
    Vooys, W
    Blijham, GH
    Groenewegen, G
    [J]. BLOOD, 1997, 90 (03) : 1150 - 1159
  • [13] Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells
    Hirakawa, S
    Hong, YK
    Harvey, N
    Schacht, V
    Matsuda, K
    Libermann, T
    Detmar, M
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (02) : 575 - 586
  • [14] Fatal bilateral chylothorax in mice lacking the integrin α9β1
    Huang, XZ
    Wu, JF
    Ferrando, R
    Lee, JH
    Wang, YL
    Farese, RV
    Sheppard, D
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (14) : 5208 - 5215
  • [15] Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype
    Jiang, XR
    Jimenez, G
    Chang, E
    Frolkis, M
    Kusler, B
    Sage, M
    Beeche, M
    Bodnar, AG
    Wahl, GM
    Tlsty, TD
    Chiu, CP
    [J]. NATURE GENETICS, 1999, 21 (01) : 111 - 114
  • [16] A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities
    Joukov, V
    Kumar, V
    Sorsa, T
    Arighi, E
    Weich, H
    Saksela, O
    Alitalo, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) : 6599 - 6602
  • [17] Joukov V, 1996, EMBO J, V15, P290
  • [18] Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
    Kinsella, TM
    Nolan, GP
    [J]. HUMAN GENE THERAPY, 1996, 7 (12) : 1405 - 1413
  • [19] Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages
    Kriehuber, E
    Breiteneder-Geleff, S
    Groeger, M
    Soleiman, A
    Schoppmann, SF
    Stingl, G
    Kerjaschki, D
    Maurer, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (06) : 797 - 808
  • [20] Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea
    Kubo, H
    Cao, RH
    Bräkenhielm, E
    Mäkinen, T
    Cao, YH
    Alitalo, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) : 8868 - 8873